Vir Biotechnology
233 hedge funds and large institutions have $604M invested in Vir Biotechnology in 2025 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 74 increasing their positions, 71 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more call options, than puts
Call options by funds: $1.87M | Put options by funds: $1.81M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
7% less capital invested
Capital invested by funds: $652M → $604M (-$47.6M)
Holders
233
Holding in Top 10
3
Calls
$1.87M
Puts
$1.81M
Top Buyers
| 1 | +$19.6M | |
| 2 | +$12M | |
| 3 | +$7.47M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.84M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.8M |
Top Sellers
| 1 | -$12.2M | |
| 2 | -$11.4M | |
| 3 | -$8.63M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.23M |
| 5 |
SCM
Sio Capital Management
New York
|
-$5.17M |